Acquiring Company
GSK plc
Acquired Company
a United States-based clinical-stage oncology specialist
Description
GSK plc is set to acquire a United States-based clinical-stage oncology specialist. This acquisition aims to enhance GSK's oncology pipeline with late-stage lung-cancer therapies. The move reflects GSK's strategic commitment to strengthen its presence in the precision cancer treatment market.
Quick answer
GSK plc is acquiring a United States-based clinical-stage oncology specialist, announced September 7, 2026.
- How much did GSK plc pay for a United States-based clinical-stage oncology specialist?
- The deal value was not disclosed.
- What does GSK plc do?
- GSK plc is a global healthcare company that researches and develops innovative pharmaceutical products, including vaccines.
- Where are GSK plc and a United States-based clinical-stage oncology specialist based?
- a United States-based clinical-stage oncology specialist is based in Palo Alto, California, United States.
- Who are the decision-makers at GSK plc?
- Fundz holds 4 contacts at GSK plc. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Pharmaceutical and Biotechnology Research
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Laprophan acquires Corporate Investment Holding (October 21, 2026)
- Senores Pharma acquires 75% stake in Apnar Pharma (August 30, 2026)
- Tarsus Pharmaceuticals to acquire Alkeus Pharmaceuticals (August 6, 2026)
- Merck KGaA to acquire Silence Therapeutics for $1.3B, $1.3B (October 19, 2026)
- Petauri acquires Franklin Pharmaceutical Consulting (October 8, 2026)
- Lifecore Biomedical, Inc. Enters Merger Agreement with Lifecore Inc. (September 28, 2026)
Who to call at GSK plc, and when
When GSK plc changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day GSK plc raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at GSK plc, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at GSK plc. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment GSK plc makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired a United States-based clinical-stage oncology specialist?
a United States-based clinical-stage oncology specialist was acquired by GSK plc. The deal was reported on September 7, 2026. GSK plc is a global healthcare company that researches and develops innovative pharmaceutical products, including vaccines. GSK plc is publicly traded (GSK) and operates in Manufacturing.
When did GSK plc acquire a United States-based clinical-stage oncology specialist?
GSK plc's acquisition of a United States-based clinical-stage oncology specialist was reported on September 7, 2026. GSK plc is set to acquire a United States-based clinical-stage oncology specialist. This acquisition aims to enhance GSK's oncology pipeline with late-stage lung-cancer therapies. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does a United States-based clinical-stage oncology specialist do?
This oncology specialist is focused on developing innovative therapies for cancer treatment. With a concentration on precision medicine, it targets specific cancer pathways to develop effective treatments. It is publicly traded (GH), operating in Biotechnology Research, and is based in Palo Alto.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.